Surmodics (SRDX)
(Delayed Data from NSDQ)
$34.38 USD
+0.16 (0.47%)
Updated May 24, 2024 04:00 PM ET
After-Market: $34.29 -0.09 (-0.26%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth F Momentum F VGM
Brokerage Reports
Surmodics, Inc. [SRDX]
Reports for Purchase
Showing records 321 - 340 ( 413 total )
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
SurModics: Improving Medical Device Outlook, Steadying IVC Sales and the Drug Coated Balloon is Progressing
Provider: The Benchmark Company
Analyst: WALD J
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Revenues and Earnings Disappoint: but Understandable to a Degree
Provider: The Benchmark Company
Analyst: WALD J
Company: Surmodics, Inc.
Industry: Medical - Products
Q2 FY2014 results mixed, yet SRDX sees positive developments, reiterate SB/$31.25PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Initiating with a Buy rating and a Price Target of $30
Provider: The Benchmark Company
Company: Surmodics, Inc.
Industry: Medical - Products
Q4 EPS beat, drug-coated balloon preclinical work completed, reiterating SB, $31.25PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q4 EPS beat, drug-coated balloon preclinical work completed, reiterating SB, $31.25PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Organizational changes announced, reiterating STRONG BUY, $31.25PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q3 results slightly below estimates, EPS guidance range raised, to STRONG BUY
Provider: FELTL & COMPANY
Analyst: HAYNOR B